Bid integrates intrinsic and extrinsic signaling in apoptosis induced by α-tocopheryl succinate in human gastric carcinoma cells

Cancer Letters

Volumn 288, Issue 1, 2010, Pages 42-49

  Zhao, Yan ^a   Li, Ruisong ^a   Xia, Wei ^a   Neuzil, Jiri ^b,c   Lu, Yuxia ^a   Zhang, Haijin ^a   Zhao, Xiujuan ^a   Zhang, Xiaohua ^a   Sun, Changhao ^a   Wu, Kun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b GRIFFITH UNIVERSITY   (Australia)

^c INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

tocopheryl succinate; Apoptosis; Bid; Gastric carcinoma

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ANTISENSE OLIGODEOXYNUCLEOTIDE; APOPTOSIS INDUCING FACTOR; CASPASE; CYTOCHROME C; DEATH RECEPTOR; FAS ANTIGEN; PROTEIN BAX; PROTEIN BID;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN SECRETION; PROTEIN TRANSPORT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH CARCINOMA;

ALPHA-TOCOPHEROL; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARCINOMA; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN TRANSPORT; RECEPTORS, DEATH DOMAIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TIME FACTORS;

TOSCANA VIRUS;

EID: 73649104836     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.06.021     Document Type: Article

References (54)

1. Hohenberger P., and Gretschel S. Gastric cancer. Lancet 362 (2003) 305-315
2. Leung W.K., Wu M.S., Kakugawa Y., Kim J.J., Yeoh K.G., Goh K.L., Wu K.C., Wu D.C., Sollano J., Kachintorn U., Gotoda T., Lin J.T., You W.C., Ng E.K., and Sung J.J. Asia pacific working group on gastric cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 9 (2008) 279-287
3. Neuzil J., Weber T., Gellert N., and Weber C. Selective cancer cell killing by α-tocopheryl succinate. Br. J. Cancer 84 (2001) 87-89
4. Prasad K.N., Kumar B., Yan W.D., Hanson A.J., and Cole W.C. α-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J. Am. Coll. Nutr. 22 (2003) 108-117
5. Neuzil J., Tomasetti M., Zhao Y., Dong L.F., Birringer M., Wang X.F., Low P., Wu K., Salvatore B.A., and Ralph S.J. Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent. Mol. Pharmacol. 71 (2007) 1185-1199
6. Ghobrial I.M., Witzig T.E., and Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 55 (2005) 178-194
7. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103 (2005) 1551-1560
8. Servais H., Van Der Smissen P., Thirion G., Van der Essen G., Van Bambeke F., Tulkens P.M., and Mingeot-Leclercq M.P. Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol. Appl. Pharmacol. 206 (2005) 321-333
9. Chun K.H., Benbrook D.M., Berlin K.D., Hong W.K., and Lotan R. The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Cancer Res. 63 (2003) 3826-3832
10. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
11. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15 (2001) 2922-2933
12. Twomey C., and McCarthy J.V. Pathways of apoptosis and importance in development. J. Cell. Mol. Med. 9 (2005) 345-359
13. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341 (1999) 233-249
14. Kroemer G. The mitochondrial permeability transition pore complex as a pharmacological target. An introduction. Curr. Med. Chem. 10 (2003) 1469-1472
15. Gadd M.E., Broekemeier K.M., Crouser E.D., Kumar J., Graff G., and Pfeiffer D.R. Mitochondrial iPLA2 activity modulates the release of cytochrome c from mitochondria and influences the permeability transition. J. Biol. Chem. 281 (2006) 6931-6939
16. Piret J.P., Arnould T., Fuks B., Chatelain P., Remacle J., and Michiels C. Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cells. Biochem. Pharmacol. 67 (2004) 611-620
17. Gross A., McDonnell J.M., and Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13 (1999) 1899-1911
18. Willis S., Day C.L., Hinds M.G., and Huang D.C. The Bcl-2-regulated apoptotic pathway. J. Cell Sci. 116 (2003) 4053-4056
19. de Graaf A.O., van den Heuvel L.P., Dijkman H.B., de Abreu R.A., Birkenkamp K.U., de Witte T., van der Reijden B.A., Smeitink J.A., and Jansen J.H. Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis. Exp. Cell Res. 299 (2004) 533-540
20. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481-490
21. Wu K., Li Y., Zhao Y., Shan Y.J., Xia W., Yu W.P., and Zhao L. Roles of Fas signaling pathway in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells. World J. Gastroenterol. 8 (2002) 982-986
22. Wu K., Zhao Y., Li G.C., and Yu W.P. c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells. World J. Gastroenterol. 10 (2004) 1110-1114
23. Zhao Y., Zhao X., Yang B., Neuzil J., and Wu K. α-Tocopheryl succinate-induced apoptosis in human gastric cancer cells is modulated by ERK1/2 and c-Jun N-terminal kinase in a biphasic manner. Cancer Lett. 247 (2007) 345-352
24. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
25. Dowsett M., Smith I.E., Ebbs S.R., Dixon J.M., Skene A., Griffith C., Boeddinghaus I., Salter J., Detre S., Hills M., Ashley S., Francis S., Walsh G., and A'Hern R. Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer. Clin. Cancer Res. 12 (2006) 1024s-1030s
26. Yang L., Cao Z., Yan H., and Wood W.C. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 63 (2003) 6815-6824
27. Sun S.Y., Hail N., and Lotan R. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. 96 (2004) 662-672
28. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5 (2005) 876-885
29. Neuzil J., Weber T., Schröder A., Lu M., Ostermann G., Gellert N., Mayne G.C., Olejnicka B., Nègre-Salvayre A., Stícha M., Coffey R.J., and Weber C. Induction of apoptosis in cancer cells by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 15 (2001) 403-415
30. Malafa M.P., and Neitzel L.T. Vitamin E succinate promotes breast cancer tumor dormancy. J. Surg. Res. 93 (2000) 163-170
31. Weber T., Dalen H., Andera L., Nègre-Salvayre A., Augé N., Sticha M., Lloret A., Terman A., Witting P.K., Higuchi M., Plasilova M., Zivny J., Gellert N., Weber C., and Neuzil J. Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with anticancer activity. Comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 42 (2003) 4277-4291
32. Wu K., Shan Y.J., Zhao Y., Yu J.W., and Liu B.H. Inhibitory effects of RRR-α-tocopheryl succinate on bezo(a)pyrene (B(a)P)-induced forestomach carcinogenesis in female mice. World J. Gastroenterol. 7 (2001) 60-65
33. Zhang Y., Ni J., Messing E.M., Chang E., Yang C.R., and Yeh S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc. Natl. Acad. Sci. USA 99 (2002) 7408-7413
34. Wang X.F., Dong L., Zhao Y., Tomasetti M., Wu K., and Neuzil J. Vitamin E analogues as anticancer agents: lessons from studies with α-tocopheryl succinate. Mol. Nutr. Food Res. 50 (2006) 675-685
35. Tomic-Vatic A., EyTina J.H., Chapmann J.M., Mahdavian E., Neuzil J., and Salvatore B.A. Vitamin E amides, a new class of vitamin E analogues with enhanced pro-apoptotic activity. Int. J. Cancer 117 (2005) 118-123
36. Wang X.F., Birringer M., Dong L.F., Veprek P., Low P., Swettenham E., Stantic M., Yuan L.H., Zobalova R., Wu K., Ledvina M., Ralph S.J., and Neuzil J. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression. Cancer Res. 67 (2007) 3337-3344
37. Hahn T., Szabo L., Gold M., Ramanathapuram L., Hurley L.H., and Akporiaye E.T. Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res. 66 (2006) 9374-9378
38. Brenner C., and Kroemer G. Apoptosis. Mitochondria - the death signal integrators. Science 289 (2000) 1150-1151
39. Degli Esposti M. Mitochondria in apoptosis: past, present and future. Biochem. Soc. Trans. 32 (2004) 493-495
40. Gogvadze V., Orrenius S., and Zhivotovsky B. Mitochondria in cancer cells: what is so special about them?. Trends Cell Biol. 18 (2008) 165-173
41. Liou A.K., Zhou Z., Pei W., Lim T.M., Yin X.M., and Chen J. BimEL up-regulation potentiates AIF translocation and cell death in response to MPTP. FASEB J. 19 (2005) 1350-1352
42. Kang Y.H., Yi M.J., Kim M.J., Park M.T., Bae S., Kang C.M., Cho C.K., Park I.C., Park M.J., Rhee C.H., Hong S.I., Chung H.Y., Lee Y.S., and Lee S.J. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 64 (2004) 8960-8967
43. L in cell death. Biochem. Biophys. Res. Commun. 333 (2005) 336-343
44. Mayorga M., Bahi N., Ballester M., Comella J.X., and Sanchis D. Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death. J. Biol. Chem. 279 (2004) 34882-34889
45. Precht T.A., Phelps R.A., Linseman D.A., Butts B.D., Le S.S., Laessig T.A., Bouchard R.J., and Heidenreich K.A. The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ. 12 (2005) 255-265
46. Yamaguchi H., Bhalla K., and Wang H.G. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res. 63 (2003) 1483-1489
47. L/Bcl-2 function. J. Biol. Chem. 281 (2006) 11819-11825
48. Yu W., Sanders B.G., and Kline K. RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 63 (2003) 2483-2491
49. Dong L.F., Low P., Dyason J., Wang X.F., Prochazka L., Witting P.K., Freeman R., Swettenham E., Valis K., Liu J., Zobalova R., Turanek J., Spitz D.R., Domann F.E., Scheffler I.E., Ralph S.J., and Neuzil J. α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 27 (2008) 4324-4335
50. Neuzil J., Wang X.F., Dong L.F., Low P., and Ralph S.J. Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett. 580 (2006) 5125-5129
51. Korsmeyer S.J., Wei M.C., Saito M., Weiler S., Oh K.J., and Schlesinger P.H. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 7 (2000) 1166-1173
52. Yin X.M. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369 (2006) 7-19
53. Chan C.W., and Housseau F. The 'kiss of death' by dendritic cells to cancer cells. Cell Death Differ. 15 (2008) 58-69
54. Tomasetti M., and Neuzil J. Vitamin E analogues and immune response in cancer treatment. Vitam. Horm. 76 (2007) 463-491